SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Human Genome Sciences, Inc. (HGSI)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
1127 105 0 HGSI
Emcee:  Jeffrey Ogbar Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
827Human Genome to sell $200 mln conv debt,shares dip Mon Sep 27, 2004 04:21 PM ET A.J. Mullen-9/28/2004
826Argeris (Jerry) N. Karabelas, Ph.D., To Become Chmn Of Human Genome Sciences BoaFiloF-9/20/2004
825Human Genome Sciences Advances Anti-Cancer Drug to Phase 2 Clinical Development nigel bates-9/8/2004
824Correction: I wrote: <<At the end of 2003, the drug was going into Phase Steven Rachbach-8/31/2004
823Today’s report of the 7,983 subject Rotterdam study involving Lp-PLA2 as a risk Steven Rachbach-8/31/2004
822Human Genome Sciences Initiates Clinical Development of New Drug for the Treatmenigel bates-8/24/2004
821Some points about the announcement that the US military has started a program toSteven Rachbach-8/22/2004
820Signals sample contract analysis is of HGSI's deal with SmithKline. Way bactuck-6/28/2004
819content.nejm.org 44&sendit=GO&searchid=1084239851423_20072&FIRSTINDESteven Rachbach-5/10/2004
818New study on Lp-PLA2 and the risk of stroke: diadexus.com pslgroup.com IntereSteven Rachbach-5/10/2004
817You could look at yesterday's events and make a case for at least 3 differenSteven Rachbach-3/26/2004
816Anthrax Treatments Promising In Tests Two Developers Say Experimental Drugs AreDoc Bones-3/9/2004
815Human Genome Sciences Announces Selection of Lymphostat-B(TM) for Participation A.J. Mullen-3/4/2004
814Regarding Lp-PLA2 and GSK-HGSI agreements. Following is a copy of a post that ISteven Rachbach-2/23/2004
813Sorry. Guess I'm just a little sensitive to bad news involving CAT at the mnigel bates-2/11/2004
812BLyS is the protein that stimulates the B cells that HGSI had in trials for an iSteven Rachbach-2/11/2004
811Cross posting this study regarding TRAIL and liver toxicity, which is inconclusituck-2/11/2004
810<i>Thus, BLyS program stopped</i> Haven't had time to listen tonigel bates-2/10/2004
809Today's Q&A: My notes from the Q&A: General tone seems to be the Steven Rachbach-2/10/2004
808i've been out of hgsi for about a month but always follow this stock becausebob zagorin-2/3/2004
807Analysis of trial failure: KGF-2 had already failed when given intravenouslSteven Rachbach-2/3/2004
806Another trial failure: Press Release Source: Human Genome Sciences, Inc. HumaSteven Rachbach-2/2/2004
805Human Genome Sciences Updates Progress of Six Drugs in Clinical Trials at JPMorgbob zagorin-1/12/2004
804Human Genome Sciences Initiates Phase 2 Clinical Trial Of LymphoStat-B(TM) for tnigel bates-1/8/2004
803Human Genome Sciences Announces License Agreement With Pfizer Thursday December bob zagorin-12/18/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News